Stockreport

FDA Approves Ziihera for HER2-Positive Biliary Tract Cancer [Yahoo! Finance]

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF with previously treated, unresectable, or metastatic HER2-positive biliary tract cancer. Warning! GuruFocus has detected 5 Warning Signs with ZYME. Independent centr [Read more]